BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38092290)

  • 1. The Prognostic Power of Preablation Stimulated Thyroglobulin in Children With Differentiated Thyroid Cancer.
    Nesari Javan F; Askari E; Shafiei S; Roshanravan V; Aghaei A; Ayati N; Zakavi SR
    Endocr Pract; 2024 Mar; 30(3):209-217. PubMed ID: 38092290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRE-ABLATION THYROGLOBULIN AND THYROGLOBULIN TO THYROID-STIMULATING HORMONE RATIO MAY BE ASSOCIATED WITH PULMONARY METASTASES IN CHILDREN WITH DIFFERENTIATED THYROID CANCER.
    Livhits MJ; Pasternak JD; Xiong M; Li N; Gosnell JE; Yeh MW; Chiu HK
    Endocr Pract; 2016 Nov; 22(11):1259-1266. PubMed ID: 27482611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Level VI lymph node dissection does not decrease radioiodine uptake in patients undergoing radioiodine ablation for differentiated thyroid cancer.
    Yoo D; Ajmal S; Gowda S; Machan J; Monchik J; Mazzaglia P
    World J Surg; 2012 Jun; 36(6):1255-61. PubMed ID: 22430670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicentric study.
    Cistaro A; Quartuccio N; Garganese MC; Villani MF; Altini C; Pizzoferro M; Piccardo A; Cabria M; Massollo M; Maghnie M; Campennì A; Siracusa M; Baldari S; Panareo S; Urso L; Bartolomei M; De Palma D; Grossi A; Mazzoletti A; Dondi F; Bertagna F; Giubbini R; Albano D
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1374-1385. PubMed ID: 34664092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between clinical and tumor features with postoperative thyroglobulin in pediatric papillary thyroid cancer.
    Tian T; Jiang L; Zhang X; Huang R; Liu B
    Surgery; 2020 Dec; 168(6):1095-1100. PubMed ID: 32948335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of radioiodine avidity and serum thyroglobulin in differentiated thyroid carcinoma with distant metastasis.
    Kim HJ; Lee JI; Kim NK; Min YK; Kim SW; Chung JH
    World J Surg; 2013 Dec; 37(12):2845-52. PubMed ID: 24085223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy analysis of (131)I therapy and predictive value of preablation stimulated thyroglobulin for lung metastases from differentiated thyroid cancer.
    Wu S; Wang H
    Ann Endocrinol (Paris); 2013 Feb; 74(1):40-4. PubMed ID: 23337017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
    Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
    J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer.
    Hasbek Z; Turgut B; Kilicli F; Altuntas EE; Yucel B
    Asian Pac J Cancer Prev; 2014; 15(6):2523-7. PubMed ID: 24761858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UNFAVORABLE RESPONSES TO RADIOIODINE THERAPY IN N1B PAPILLARY THYROID CANCER: A PROPENSITY SCORE MATCHING STUDY.
    Liu YQ; Li H; Liu JR; Lin YS
    Endocr Pract; 2019 Dec; 25(12):1286-1294. PubMed ID: 31412228
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.
    Lima N; Cavaliere H; Tomimori E; Knobel M; Medeiros-Neto G
    J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of stimulated pre-ablation thyroglobulin as a prognostic marker in patients with differentiated thyroid carcinoma treated with radioiodine.
    Nóbrega G; Cavalcanti M; Leite V; Vilar L; Brandão SCS
    Endocrine; 2022 Jun; 76(3):642-647. PubMed ID: 35237910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of post-ablation stimulated thyroglobulin in differentiated thyroid cancer patients with biochemical incomplete response: a bi-center observational study.
    Wang Y; Wu J; Jiang L; Zhang X; Liu B
    Endocrine; 2022 Apr; 76(1):109-115. PubMed ID: 35094313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of Stimulated Thyroglobulin and Antithyroglobulin Antibody Predicts the Efficacy and Prognosis of
    Pan M; Li Z; Jia M; Lu X
    Front Endocrinol (Lausanne); 2022; 13():857057. PubMed ID: 35464061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of distant metastasis at the time of ablation in children with differentiated thyroid cancer: the value of pre-ablation stimulated thyroglobulin.
    Liu L; Huang F; Liu B; Huang R
    J Pediatr Endocrinol Metab; 2018 Jul; 31(7):751-756. PubMed ID: 29953410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value for excellent response to initial therapy in differentiated thyroid cancer: preablation-stimulated thyroglobulin better than the TNM stage.
    Zhang Y; Hua W; Zhang X; Peng J; Liang J; Gao Z
    Nucl Med Commun; 2018 May; 39(5):405-410. PubMed ID: 29557849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of differentiated thyroid carcinoma in children and adolescents.
    Negre Busó M; García Burillo A; Simó Perdigó M; Galofré Mora P; Boronat de Ferrater M; Cuberas Borrós G; Sábado Álvarez C; Castell Conesa J
    J Pediatr Endocrinol Metab; 2020 Nov; 33(11):1431-1441. PubMed ID: 32877364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to Therapy Assessment in Intermediate-Risk Thyroid Cancer Patients: Is Thyroglobulin Stimulation Required?
    Moreno I; Hirsch D; Duskin-Bitan H; Dicker-Cohen T; Shimon I; Robenshtok E
    Thyroid; 2020 Jun; 30(6):863-870. PubMed ID: 31928205
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of Postoperative Stimulated Thyroglobulin as Prognostic Factor for Differentiated Thyroid Cancer in Children and Adolescents.
    Zanella A; Scheffel RS; Pasa MW; Dora JM; Maia AL
    Thyroid; 2017 Jun; 27(6):787-792. PubMed ID: 28292215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.